Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician

References

• Mond HG, Irwin M, Ector H, et al. The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol. 2008;31(9):1202–1212. doi:10.1111/j.1540-8159.2008.01164.x.
   PubMed Web of Science ®Google Scholar
• Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm. 2008;5(6):934–955. doi:10.1016/j.hrthm.2008.04.015.
   PubMed Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2013;61(3):e6–75. doi:10.1016/j.jacc.2012.11.007.
   PubMed Web of Science ®Google Scholar
• Zhan C, Baine WB, Sedrakyan A, et al. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med. 2008;23(Suppl. 1):13–19. doi:10.1007/s11606-007-0392-0.
   PubMed Web of Science ®Google Scholar
• Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553–1561. doi:10.1161/CIRCULATIONAHA.110.976076.
   PubMed Web of Science ®Google Scholar
• Ellenbogen KA, Hellkamp AS, Wilkoff BL, et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol. 2003;92(6):740–741.
   PubMed Web of Science ®Google Scholar
• Nowak B, Misselwitz B. Expert committee ‘Pacemaker’, Institute of Quality Assurance Hessen, et al. Do gender differences exist in pacemaker implantation?–results of an obligatory external quality control program. Europace. 2010;12(2):210–215. doi:10.1093/europace/eup312.
   PubMed Web of Science ®Google Scholar
• Tobin K, Stewart J, Westveer D, et al. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol. 2000;85(6):774–776, A9.
   PubMed Web of Science ®Google Scholar
• Eberhardt F, Bode F, Bonnemeier H, et al. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart. 2005;91(4):500–506. doi:10.1136/hrt.2003.025411.
   PubMed Web of Science ®Google Scholar
• Lee DS, Krahn AD, Healey JS, et al. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55(8):774–782. doi:10.1016/j.jacc.2009.11.029.
   PubMed Web of Science ®Google Scholar
• Duray GZ, Schmitt J, Cicek-Hartvig S, et al. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace. 2009;11(3):297–302. doi:10.1093/europace/eun322.
   PubMed Web of Science ®Google Scholar
• Dewland TA, Pellegrini CN, Wang Y, et al. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol. 2011;58(10):1007–1013. doi:10.1016/j.jacc.2011.04.039.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Greiner MA, Peterson ED, et al. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002–2005. Circ Arrhythm Electrophysiol. 2008;1(4):240–249. doi:10.1161/CIRCEP.108.777888.
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001–1006. doi:10.1016/j.jacc.2011.04.033.
   PubMed Web of Science ®Google Scholar
• Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999. Am Heart J. 2004;147(4):582–586. doi:10.1016/j.ahj.2003.06.005.
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669–675. doi:10.1001/archinte.167.7.669.
   PubMedGoogle Scholar
• Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest. 2004;126(4):1177–1186. doi:10.1378/chest.126.4.1177.
   PubMed Web of Science ®Google Scholar
• Kutinsky IB, Jarandilla R, Jewett M, et al. Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol. 2010;3(4):312–318. doi:10.1161/CIRCEP.109.917625.
   PubMed Web of Science ®Google Scholar
• Michaud GF, Pelosi F Jr, Noble MD, et al. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol. 2000;35(7):1915–1918.
   PubMed Web of Science ®Google Scholar
• Robinson M, Healey JS, Eikelboom J, et al. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009;32(3):378–382. doi:10.1111/j.1540-8159.2008.02247.x.
   PubMed Web of Science ®Google Scholar
• Alter P, Waldhans S, Plachta E, et al. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol. 2005;28(9):926–932. doi:10.1111/j.1540-8159.2005.00195.x.
   PubMed Web of Science ®Google Scholar
• Kiviniemi MS, Pirnes MA, Eränen HJ, et al. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol. 1999;22(5):711–720.
   PubMed Web of Science ®Google Scholar
• Wiegand UK, Bode F, Bonnemeier H, et al. Long-term complication rates in ventricular, single lead VDD, and dual chamber pacing. Pacing Clin Electrophysiol. 2003;26(10):1961–1969.
   PubMed Web of Science ®Google Scholar
• Klein RC, Raitt MH, Wilkoff BL, et al. Analysis of implantable cardioverter defibrillator therapy in the antiarrhythmics versus implantable defibrillators (AVID) trial. J Cardiovasc Electrophysiol. 2003;14(9):940–948.
   PubMed Web of Science ®Google Scholar
• Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51(14):1357–1365. doi:10.1016/j.jacc.2007.09.073.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Schuger C, Beck CA, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275–2283. doi:10.1056/NEJMoa1211107.
   PubMed Web of Science ®Google Scholar
• Gasparini M, Proclemer A, Klersy C, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA. 2013;309(18):1903–1911. doi:10.1001/jama.2013.4598.
   PubMed Web of Science ®Google Scholar
• Schwartz IS, Pervez N. Bacterial endocarditis associated with a permanent transvenous cardiac pacemaker. JAMA. 1971;218(5):736–737.
   PubMed Web of Science ®Google Scholar
• Corman LC, Levison ME. Sustained bacteremia and transvenous cardiac pacemakers. JAMA. 1975;233(3):264–266.
   PubMed Web of Science ®Google Scholar
• Arber N, Pras E, Copperman Y, et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore). 1994;73(6):299–305.
   PubMed Web of Science ®Google Scholar
• Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol. 2006;29(2):142–145. doi:10.1111/j.1540-8159.2006.00307.x.
   PubMed Web of Science ®Google Scholar
• Lekkerkerker JC, Van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart. 2009;95(9):715–720. doi:10.1136/hrt.2008.151985.
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007;45(2):166–173. doi:10.1086/518889.
   PubMed Web of Science ®Google Scholar
• Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116(12):1349–1355. doi:10.1161/CIRCULATIONAHA.106.678664.
   PubMed Web of Science ®Google Scholar
• Johansen JB, Jørgensen OD, Møller M, et al. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011;32(8):991–998. doi:10.1093/eurheartj/ehq497.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–477. doi:10.1161/CIRCULATIONAHA.109.192665.
   PubMed Web of Science ®Google Scholar
• De Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2(1):29–34. doi:10.1161/CIRCEP.108.795906.
   PubMed Web of Science ®Google Scholar
• Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18):1796–1801.
   PubMed Web of Science ®Google Scholar
• World-wide randomized antibiotic envelope infection prevention trial (WRAP-IT); [cited 2015 Nov 27]. Available from: https://Clinicaltrials.gov/ct2/show/study/NCT02277990?show_locs=Y#locn.
   Google Scholar
• Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362(1):18–26. doi:10.1056/NEJMoa0810988.
   PubMed Web of Science ®Google Scholar
• Remmelts HH, Meine M, Loh P, et al. Infection after ICD implantation: operating room versus cardiac catheterisation laboratory. Neth Heart J. 2009;17(3):95–100.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Bhandari AK, Watanuki M, et al. High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circ J. 2002;66(8):746–750.
   PubMed Web of Science ®Google Scholar
• Jamula E, Douketis JD, Schulman S. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost. 2008;6(10):1615–1621. doi:10.1111/j.1538-7836.2008.03080.x.
   PubMed Web of Science ®Google Scholar
• Zhu D, Ahmed I. Perioperative management of anticoagulation in patients on warfarin therapy undergoing surgery for cardiac implantable electronic devices. J Arrhythmia. 2013;29(3):162–167. doi:10.1016/j.joa.2013.01.010.
   Google Scholar
• Birnie DH, Healey JS, Wells GA, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368(22):2084–2093. doi:10.1056/NEJMoa1302946.
   PubMed Web of Science ®Google Scholar
• Du L, Zhang Y, Wang W, et al. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis. Pacing Clin Electrophysiol. 2014;37(11):1573–1586. doi:10.1111/pace.12517.
   PubMed Web of Science ®Google Scholar
• Mar PL, Familtsev D, Ezekowitz MD, et al. Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: review of the literature and recommendations for specific populations and procedures. Int J Cardiol. 2016;202:578–585. doi:10.1016/j.ijcard.2015.09.035.
   PubMed Web of Science ®Google Scholar
• Kim JB, Spevack DM, Tunick PA, et al. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr. 2008;21(3):284–287. doi:10.1016/j.echo.2007.05.022.
   PubMed Web of Science ®Google Scholar
• Höke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart. 2014;100(12):960–968. doi:10.1136/heartjnl-2013-304673.
   PubMed Web of Science ®Google Scholar
• Al-Bawardy R, Krishnaswamy A, Bhargava M, et al. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review. Clin Cardiol. 2013;36(5):249–254. doi:10.1002/clc.22104.
   PubMed Web of Science ®Google Scholar
• Lin G, Nishimura RA, Connolly HM, et al. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol. 2005;45(10):1672–1675. doi:10.1016/j.jacc.2005.02.037.
   PubMed Web of Science ®Google Scholar
• Kirkfeldt RE, Johansen JB, Nohr EA, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–1194. doi:10.1093/eurheartj/eht511.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Lucas FL, Jollis JG, et al. The relation between patients’ outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries. J Am Coll Cardiol. 2005;46(8):1536–1540. doi:10.1016/j.jacc.2005.04.063.
   PubMed Web of Science ®Google Scholar
• Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol. 1989;13(4):917–921.
   PubMed Web of Science ®Google Scholar
• Curtis AB, Ellenbogen KA, Hammill SC, et al. Clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm. 2004;1(3):371–375. doi:10.1016/j.hrthm.2004.08.003.
   PubMed Web of Science ®Google Scholar
• Coromilas J. Physician credentials and ICD implantation: certified “electricians” best deal with electrical problems. JAMA. 2009;301(16):1713–1714. doi:10.1001/jama.2009.554.
   PubMed Web of Science ®Google Scholar
• Eckstein J, Koller MT, Zabel M, et al. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation. 2008;117(21):2727–2733. doi:10.1161/CIRCULATIONAHA.107.740670.
   PubMed Web of Science ®Google Scholar
• Pedersen SS, VAN DEN Berg M, Erdman RA, et al. Increased anxiety in partners of patients with a cardioverter-defibrillator: the role of indication for ICD therapy, shocks, and personality. Pacing Clin Electrophysiol. 2009;32(2):184–192. doi:10.1111/j.1540-8159.2008.02201.x.
   PubMed Web of Science ®Google Scholar
• Koneru JN, Swerdlow CD, Wood MA, et al. Minimizing inappropriate or “unnecessary” implantable cardioverter-defibrillator shocks: appropriate programming. Circ Arrhythm Electrophysiol. 2011;4(5):778–790. doi:10.1161/CIRCEP.110.961243.
   PubMed Web of Science ®Google Scholar
• Peterson PN, Varosy PD, Heidenreich PA, et al. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA. 2013;309(19):2025–2034. doi:10.1001/jama.2013.4982.
   PubMed Web of Science ®Google Scholar
• Russo AM, Stainback RF, Bailey SR, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College Of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society Of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm. 2013;10(4):e11–58. doi:10.1016/j.hrthm.2013.01.008.
   Web of Science ®Google Scholar
• Wilkoff BL, Williamson BD, Stern RS, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (primary prevention parameters evaluation) study. J Am Coll Cardiol. 2008;52(7):541–550. doi:10.1016/j.jacc.2008.05.011.
   PubMed Web of Science ®Google Scholar
• Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE rx II) trial results. Circulation. 2004;110(17):2591–2596. doi:10.1161/01.CIR.0000145610.64014.E4.
   PubMed Web of Science ®Google Scholar
• Swerdlow CD, Gunderson BD, Ousdigian KT, et al. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study. Circulation. 2010;122(15):1449–1455. doi:10.1161/CIRCULATIONAHA.110.962407.
   PubMed Web of Science ®Google Scholar
• Saksena S. Antiarrhythmic device advisories and recalls: managing an increasingly vulnerable process. Pacing Clin Electrophysiol. 1999;22(6 Pt. 1):950–952.
   PubMed Web of Science ®Google Scholar
• Maisel WH, Sweeney MO, Stevenson WG, et al. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA. 2001;286(7):793–799.
   PubMed Web of Science ®Google Scholar
• Hauser RG, Kallinen LM, Almquist AK, et al. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2007;4(7):892–896. doi:10.1016/j.hrthm.2007.03.041.
   PubMed Web of Science ®Google Scholar
• Hauser RG, McGriff D, Retel LK. Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect. Heart Rhythm. 2012;9(5):742–749. doi:10.1016/j.hrthm.2011.12.019.
   PubMed Web of Science ®Google Scholar
• Liu J, Brumberg G, Rattan R, et al. Class I recall of defibrillator leads: a comparison of the sprint fidelis and riata families. Heart Rhythm. 2012;9(8):1251–1255. doi:10.1016/j.hrthm.2012.04.003.
   PubMed Web of Science ®Google Scholar
• Henrikson CA, Maytin M, Epstein LM. Think before you pull–not every lead has to come out. Circ Arrhythm Electrophysiol. 2010;3(4):409–412; discussion 412. doi:10.1161/CIRCEP.110.952242.
   PubMed Web of Science ®Google Scholar
• Glikson M, Suleiman M, Luria DM, et al. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients? Heart Rhythm. 2009;6(1):65–68. doi:10.1016/j.hrthm.2008.10.012.
   PubMed Web of Science ®Google Scholar
• Maytin M, Epstein LM, Henrikson CA. Lead extraction is preferred for lead revisions and system upgrades: when less is more. Circ Arrhythm Electrophysiol. 2010;3(4):413–424; discussion 424. doi:10.1161/CIRCEP.110.954107.
   PubMed Web of Science ®Google Scholar
• Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: heart rhythm society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6(7):1085–1104. doi:10.1016/j.hrthm.2009.05.020.
   PubMed Web of Science ®Google Scholar
• Byrd CL, Wilkoff BL, Love CJ, et al. Intravascular extraction of problematic or infected permanent pacemaker leads: 1994–1996. U.S. extraction database, MED institute. Pacing Clin Electrophysiol. 1999;22(9):1348–1357.
   PubMed Web of Science ®Google Scholar